TrialNature communications2024

Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial.

Jing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.